Citation: | ZHAO Hua, LIU Dawei. How to Implement Personalized Therapy According to Clinical Guidelines: From International Guidelines for Management of Sepsis and Septic Shock[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 174-179. DOI: 10.12290/xhyxzz.2021-0811 |
[1] |
Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis compaign: international guidelines for management of sepsis and septic shock 2021[J]. Crit Care Med, 2021, 49: e1063-e1143.
|
[2] |
Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock[J]. N Engl J Med, 2014, 370: 1583-1593. DOI: 10.1056/NEJMoa1312173
|
[3] |
Lamontagne F, Richards-Belle A, Thomas K, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial[J]. JAMA, 2020, 323: 938-949. DOI: 10.1001/jama.2020.0930
|
[4] |
Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial[J]. JAMA, 2019, 321: 654-664. DOI: 10.1001/jama.2019.0071
|
[5] |
Zampieri FG, Damiani LP, Bakker J, et al. Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock, A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial[J]. Am J Respir Crit Care Med, 2020, 201: 423-429. DOI: 10.1164/rccm.201905-0968OC
|
[6] |
Liu R, Greenstein JL, Granite SJ, et al. Data-driven discovery of a novel sepsis preshock state predicts impending septic shock in the ICU[J]. Sci Rep, 2019, 9: 6145. DOI: 10.1038/s41598-019-42637-5
|
[7] |
De Backer D, Orbegozo Cortes D, Donadello K, et al. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock[J]. Virulence, 2014, 5: 73-79. DOI: 10.4161/viru.26482
|
[8] |
刘大为, 王小亭, 张宏民, 等. 重症血流动力学治疗——北京共识[J]. 中华内科杂志, 2015, 54: 248-271. DOI: 10.3760/cma.j.issn.0578-1426.2015.03.021
|
[9] |
Beaubien-Souligny W, Rola P, Haycock K, et al. Quantifying systemic congestion with Point-Of-Care ultrasound: development of the venous excess ultrasound grading system[J]. Ultrasound J, 2020, 12: 16. DOI: 10.1186/s13089-020-00163-w
|
[10] |
De-Lima-Oliveira M, Salinet ASM, Nogueira RC, et al. Intracranial Hypertension and Cerebral Autoregulation: A systematic review and meta-analysis[J]. World Neurosurg, 2018, 113: 110-124. DOI: 10.1016/j.wneu.2018.01.194
|
[11] |
Sheridan DC, Cloutier R, Kibler A, et al. Cutting-Edge technology for rapid beside assessment of capillary refill time for early diagnosis and resuscitation of sepsis[J]. Front Med (Lausanne), 2020, 7: 612303.
|
[12] |
Geri G, Vignon P, Aubry A, et al. Cardiovascular clusters in septic shock combining clinical and echocardiographic parameters: a posthoc analysis[J]. Intensive Care Med, 2019, 45: 657-667. DOI: 10.1007/s00134-019-05596-z
|
[13] |
Du W, Liu D, Long Y, et al. The β-Blocker Esmolol Restores the Vascular Waterfall Phenomenon After Acute Endotoxemia[J]. Crit Care Med, 2017, 45: e1247-e1253. DOI: 10.1097/CCM.0000000000002721
|
[14] |
Lat I, Coopersmith CM, De Backer D, et al. The surviv-ing sepsis campaign: fluid resuscitation and vasopressor therapy research priorities in adult patients[J]. Intensive Care Med Exp, 2021, 9: 10. DOI: 10.1186/s40635-021-00369-9
|
[15] |
Khanna A, English SW, Wang XS, et al. Angiotensin Ⅱ for the Treatment of Vasodilatory Shock[J]. N Engl J Med, 2017, 377: 419-430. DOI: 10.1056/NEJMoa1704154
|
[16] |
Porizka M, Kopecky P, Dvorakova H, et al. Methylene blue administration in patients with refractory distributive shock-a retrospective study[J]. Sci Rep, 2020, 10: 1828. DOI: 10.1038/s41598-020-58828-4
|
[17] |
Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock[J]. N Engl J Med, 2008, 358: 877-887. DOI: 10.1056/NEJMoa067373
|
[18] |
Gordon AC, Mason AJ, Thirunavukkarasu N, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial[J]. JAMA, 2016, 316: 509-518. DOI: 10.1001/jama.2016.10485
|
[19] |
Nagendran M, Russell JA, Walley KR, et al. Vasopressin in septic shock: an individual patient data meta-analysis of randomised controlled trials[J]. Intensive Care Med, 2019, 45: 844-855. DOI: 10.1007/s00134-019-05620-2
|
[20] |
Liu ZM, Chen J, Kou Q, et al. Terlipressin versus norepinephrine as infusion in patients with septic shock: a multicentre, randomised, double-blinded trial[J]. Intensive Care Med, 2018, 44: 1816-1825. DOI: 10.1007/s00134-018-5267-9
|